Stonebridge Financial Group, LLC/CA’s Boston Scientific BSX Stock Holding History

Stonebridge Financial Group, LLC/CA’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$304K	Buy	+7,146	New	+$388K	0.04%	222

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Stonebridge Financial Group, LLC/CA's BSX Position: Q2 2026 in Review

Stonebridge Financial Group, LLC/CA opened a new position in Boston Scientific (BSX) in Q2 2026: 7,146 shares worth $304K. The stake represents 0.04% of the portfolio and ranks #222 among its holdings.

1,176 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Stonebridge Financial Group, LLC/CA held 7,146 shares of Boston Scientific worth $304K as of Q2 2026.
Boston Scientific was a new Stonebridge Financial Group, LLC/CA position in Q2 2026.
Boston Scientific made up 0.04% of Stonebridge Financial Group, LLC/CA's portfolio in Q2 2026, its #222 holding.
1,176 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Stonebridge Financial Group, LLC/CA's 13F filing for Q2 2026, filed 13 Aug 2026.